NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone

Cell Death & Disease
Zachary MooreDavid A Boothman

Abstract

Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors (e.g., FK866) target the most active pathway of NAD(+) synthesis in tumor cells, but lack tumor-selectivity for use as a single agent. Reducing NAD(+) pools by inhibiting NAMPT primed pancreatic ductal adenocarcinoma (PDA) cells for poly(ADP ribose) polymerase (PARP1)-dependent cell death induced by the targeted cancer therapeutic, β-lapachone (β-lap, ARQ761), independent of poly(ADP ribose) (PAR) accumulation. β-Lap is bioactivated by NADPH:quinone oxidoreductase 1 (NQO1) in a futile redox cycle that consumes oxygen and generates high levels of reactive oxygen species (ROS) that cause extensive DNA damage and rapid PARP1-mediated NAD(+) consumption. Synergy with FK866+β-lap was tumor-selective, only occurring in NQO1-overexpressing cancer cells, which is noted in a majority (∼85%) of PDA cases. This treatment strategy simultaneously decreases NAD(+) synthesis while increasing NAD(+) consumption, reducing required doses and treatment times for both drugs and increasing potency. These complementary mechanisms caused profound NAD(P)(+) depletion and inhibited glycolysis, driving down adenosine triphosphate levels and preventing recovery normally observed with either agent ...Continue Reading

References

Dec 1, 1992·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·M Suzuki, M Kurata
Feb 22, 2000·The Journal of Biological Chemistry·J J PinkD A Boothman
Oct 29, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C ColussiL Ghibelli
Mar 30, 2001·The Journal of Biological Chemistry·C TagliarinoD A Boothman
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·W YingR A Swanson
May 17, 2003·Cancer Biology & Therapy·Colleen TagliarinoDavid A Boothman
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·De-Maw ChuangVladimir V Senatorov
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathryn E ReinickeDavid A Boothman
Jul 9, 2005·Molecular Carcinogenesis·Anne M LewisJoseph J Cullen
Jul 27, 2006·Journal of Molecular Histology·Melissa S BentleDavid A Boothman
Aug 22, 2006·The Journal of Biological Chemistry·Melissa S BentleDavid A Boothman
Jul 5, 2007·Proceedings of the National Academy of Sciences of the United States of America·Erik A BeyDavid A Boothman
Aug 19, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·R E SavageT C K Chan
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Karen Kate DavidValina Lynn Dawson
Jan 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Long Shan LiDavid A Boothman
Apr 16, 2011·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Uffe Høgh OlesenMaxwell Sehested
Sep 29, 2012·Nature Reviews. Cancer·Alberto ChiarugiMathias Ziegler
Feb 19, 2013·Molecular Aspects of Medicine·László VirágFrancisco Javier Oliver
Jun 29, 2013·The British Journal of Dermatology·H A Rovito, J E Oblong
Sep 13, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Claudia C S ChiniEduardo N Chini
Jan 10, 2014·Neoplasia : an International Journal for Oncology Research·Thomas O'BrienDeepak Sampath
Jan 24, 2014·Nature Reviews. Molecular Cell Biology·Tom Vanden BerghePeter Vandenabeele
Apr 23, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Fengjiao ZhangTerrence J Monks
Jul 6, 2014·Proceedings of the National Academy of Sciences of the United States of America·Shaida A AndrabiTed M Dawson

❮ Previous
Next ❯

Citations

Feb 24, 2016·Biosensors & Bioelectronics·Dimithree KahandaJason D Slinker
Dec 30, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xinpeng MaJinming Gao
Jun 17, 2016·Molecular & Cellular Oncology·Anne Roulston, Gordon C Shore
Sep 15, 2015·Seminars in Cell & Developmental Biology·Orianne OlivaresChristina Halsey
May 18, 2016·Expert Review of Anticancer Therapy·Hang ChenCanhua Huang
Nov 7, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Barry E KennedyShashi A Gujar
Dec 18, 2016·Biochemical and Biophysical Research Communications·Vladimir L KolossovH Rex Gaskins
Jun 10, 2016·Scientific Reports·Susan Dina GhiassianJoseph Loscalzo
Aug 2, 2017·Antioxidants & Redox Signaling·Joshua E LewisMelissa L Kemp
Nov 9, 2017·Antioxidants & Redox Signaling·Xiaofei ChenCristina M Furdui
Aug 20, 2018·International Journal of Cancer. Journal International Du Cancer·Ekaterina PylaevaJadwiga Jablonska
Jun 4, 2016·Molecular Medicine·Zhiqiang ZhaoLijun Di
Jan 1, 2019·Journal of Biochemical and Molecular Toxicology·Ghazale CheraghiMir-Jamal Hosseini
Feb 6, 2017·Oncotarget·Cornelia N MutzHeinrich Kovar
Dec 15, 2015·Oncotarget·Giovanna SocialiSantina Bruzzone
Nov 22, 2017·Oncotarget·Jair Machado Espindola-NettoEduardo N Chini
Jul 10, 2019·International Reviews of Immunology·Manindra Singh, Fabian Benencia
Mar 4, 2017·Expert Opinion on Emerging Drugs·Junji Furuse, Fumio Nagashima
Jan 5, 2020·Acta Physiologica·Roldan M de GuiaJonas T Treebak
Jun 2, 2020·Frontiers in Pharmacology·Ubaldina GalliAmbra A Grolla
Jan 9, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edward A MoteaDavid A Boothman
Nov 8, 2020·European Journal of Medicinal Chemistry·Qijie GongXiaojin Zhang
Feb 3, 2020·Redox Biology·Laura TorrenteGina M DeNicola
Aug 12, 2018·Biosensors & Bioelectronics·Dimithree KahandaJason D Slinker
Jun 3, 2021·Clinical & Experimental Metastasis·Jenna A MosierCynthia A Reinhart-King
Jun 3, 2021·Nutrients·Moustafa S GhanemAlessio Nencioni

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
transfections

Related Concepts

Related Feeds

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis